The clinical efficacy of combination nebulized anticholinergic and adrenergic bronchodilators vs nebulized adrenergic bronchodilator alone in acute asthma

Chest

Volumn 111, Issue 2, 1997, Pages 311-315

  FitzGerald, J Mark ^a,b   Grunfeld, Anton ^a   Pare, Peter D ^a   Levy, Robert D ^a   Newhouse, Michael T ^a   Hodder, Richard ^a   Chapman, Kenneth R ^a  

^a VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

acute asthma; bronchodilator therapy; ipratropium bromide; salbutamol

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; IPRATROPIUM BROMIDE; METHYLPREDNISOLONE; OXYGEN; SALBUTAMOL SULFATE; THEOPHYLLINE;

ADULT; ARTICLE; ASTHMA; BRONCHODILATATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MIXTURE; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEBULIZATION; OXYGEN THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING;

EID: 0031017651     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.111.2.311     Document Type: Article

References (16)

1. FitzGerald JM, Hargreave FE. The assessment and management of acute life-threatening asthma. Chest 1989; 95:888-94
2. Hargreave FE, Dolovich J, Newhouse MT. The assessment and treatment of asthma: a conference report. J Allergy Clin Immunol 1990; 85:1098-1111
3. Morley TF, Marozsane E, Zappasodi ST, et al. Comparison be beta-adrenergic agents delivered by nebulizer versus metered-dose inhaler with inspirease in hospitalized asthmatic patients. Chest 1988; 94:1205-10
4. Turner MT, FitzGerald JM. An overview of the optimal delivery of bronchodilators in asthma and COPD [abstract]. Am Rev Respir Dis 145(suppl)
5. Chapman K. The role of anticholinergics in the management of severe, acute asthma. Res Clin Forums 1993; 15:35-41
6. Rebuck AS, Chapman KR, Abboud R, et al. Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room. Am J Med 1987; 82:59-64
7. Louw SJ, Goldin JG, Varis S. Relative efficacy of nebulized ipratropium bromide and fenoterol in acute severe asthma. S Afr Med J 1990; 77:24-6
8. Leary B, Gomm SA, Allen SC. Comparison of nebulized salbutamol with nebulized ipratropium bromide in acute asthma. Br J Dis Chest 1983; 77:159-63
9. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma: American Thoracic Society. Am Rev Respir Dis 1987; 136:225-44
10. O'Driscoll BR, Taylor RJ, Hursley MG, et al. Nebulized salbutamol with and without ipratropium bromide in acute airflow obstruction. Lancet 1989; 11:1418-20
11. Higgins RM, Stradling JR, Lane DJ. Should ipratropium bromide be added to beta agonists in the treatment of acute severe asthma? Chest 1988; 94:718-22
12. Ward MJ, MacFarlane JT, Davies D. A place for ipratropium bromide in the treatment of severe acute asthma. Br J Dis Chest 1985; 79:394-98
13. Rossing TH, Fanta CH, McFadden ER Jr. Effect of outpatient treatment of asthma with beta agonists on the response to sympathomimetics in an emergency room. Am J Med 1983; 75:781-84
14. Garrett JE, Town I, for the New Zealand Combivent Study Group. Comparison of nebulization therapy combining ipratropium bromide (0.05 mg) plus salbutamol sulphate (3.0 mg) alone in acute asthma [abstract 450P]. Thorax 1995; 50:4
15. Schuh S, Johnson DW, Callahan S, et al. Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose salbutamol therapy in severe childhood asthma. Pediatrics 1995; 126:639-45
16. Barnes NC. Effects of corticosteroids in acute severe asthma. Thorax 1992; 47:582-83